CARE™ Needs Assessment: Innovation and Access in Rheumatic Diseases
For patients with rheumatic diseases (RD), there are multiple currently available therapies that have helped to improve patient outcomes over the last few years. Emerging, innovative treatments have the potential to further improve care for patients with RD and will provide us with even more choice and greater treatment flexibility. The CARE™ Faculty is interested in the views of Canadian rheumatologists with regards to the impact of new agents in Canada and access to these therapies. We thank you in advance for your valuable feedback! The results from this needs assessment will be shared in future CARE™ publications.